Related references
Note: Only part of the references are listed.Non-classical transpeptidases yield insight into new antibacterials
Pankaj Kumar et al.
NATURE CHEMICAL BIOLOGY (2017)
Mutation in an Unannotated Protein Confers Carbapenem Resistance in Mycobacterium tuberculosis
Pankaj Kumar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates
Dan Zhang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Optimal dosing regimen of biapenem in Chinese patients with lower respiratory tract infections based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation
Jing Dong et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Carbapenems against Mycobacterium tuberculosis: a review of the evidence
D. Jaganath et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
Pharmacokinetics and brain penetration of carbapenems in mice
Kazuaki Matsumoto et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2016)
β-Lactams against Tuberculosis - New Trick for an Old Dog?
Andreas H. Diacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Repurposing clinically approved cephalosporins for tuberculosis therapy
Santiago Ramon-Garcia et al.
SCIENTIFIC REPORTS (2016)
Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus
Amit Kaushik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Targeting DnaN for tuberculosis therapy using novel griselimycins
Angela Kling et al.
SCIENCE (2015)
Rapid Cytolysis of Mycobacterium tuberculosis by Faropenem, an Orally Bioavailable β-Lactam Antibiotic
Neeraj Dhar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
In Vitro Susceptibility of Mycobacterium tuberculosis Isolates to an Oral Carbapenem Alone or in Combination with β-Lactamase Inhibitors
Yasuhiro Horita et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Nonclassical Transpeptidases of Mycobacterium tuberculosis Alter Cell Size, Morphology, the Cytosolic Matrix, Protein Localization, Virulence, and Resistance to β-Lactams
Maia K. Schoonmaker et al.
JOURNAL OF BACTERIOLOGY (2014)
In Vitro Cross-Linking of Mycobacterium tuberculosis Peptidoglycan by L,D-Transpeptidases and Inactivation of These Enzymes by Carbapenems
Mathilde Cordillot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
In Vitro and In Vivo Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosis
Suresh Solapure et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis
Ian M. Rosenthal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Meropenem inhibits D,D-carboxypeptidase activity in Mycobacterium tuberculosis
Pradeep Kumar et al.
MOLECULAR MICROBIOLOGY (2012)
Targeting the Cell Wall of Mycobacterium tuberculosis: Structure and Mechanism of L,D-Transpeptidase 2
Sabri B. Erdemli et al.
STRUCTURE (2012)
Sterilizing Activity of Novel TMC207-and PA-824-Containing Regimens in a Murine Model of Tuberculosis
Rokeya Tasneen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Carbapenems: Past, Present, and Future
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The Mycobacterium tuberculosis protein LdtMt2 is a nonclassical transpeptidase required for virulence and resistance to amoxicillin
Radhika Gupta et al.
NATURE MEDICINE (2010)
Comparison of the Pharmacodynamics of Biapenem in Bronchial Epithelial Lining Fluid in Healthy Volunteers Given Half-Hour and Three-Hour Intravenous Infusions
Eiki Kikuchi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
Jean-Emmanuel Hugonnet et al.
SCIENCE (2009)
Pharmacokinetic-pharmacodynamic target attainment analysis of biapenem in adult patients: A dosing strategy
Kazuro Ikawa et al.
CHEMOTHERAPY (2008)
Parenteral carbapenems
P. M. Shah
CLINICAL MICROBIOLOGY AND INFECTION (2008)
The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by L,D-transpeptidation
Marie Lavollay et al.
JOURNAL OF BACTERIOLOGY (2008)
Crystal structure and activity studies of the Mycobacterium tuberculosis β-lactamase reveal its critical role in resistance to β-lactam antibiotics
Feng Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Comparative pharmacokinetics of the carbapenems - Clinical implications
JW Mouton et al.
CLINICAL PHARMACOKINETICS (2000)
Share Paper
